2022
DOI: 10.3389/fcell.2022.883996
|View full text |Cite
|
Sign up to set email alerts
|

Reproductive and Developmental Toxicity Assessment of Human Umbilical Cord Mesenchymal Stem Cells in Rats

Abstract: Objective: Human umbilical cord mesenchymal stem cells (hUC-MSCs) have shown very attractive potential in clinical applications for the treatment of various diseases. However, the data about the reproductive and developmental toxicity of hUC-MSCs remains insufficient. Thus, we assessed the potential effects of intravenous injection of hUC-MSCs on reproduction and development in Sprague-Dawley rats.Methods: In the fertility and early embryonic development study, hUC-MSCs were administered at dose levels of 0, 6… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 41 publications
0
3
0
Order By: Relevance
“…This is consistent with the alleviation of pulmonary embolism achieved by vascular expansion in the above reference. The symptoms of coma, decreased respiration, dilated pupils, decreased activity, and mental exhaustion in monkeys after repeated doses of hUC-MSCs (on the 3rd/4th dose prior to dilution of the concentration) may be typical of those associated with pulmonary embolism, consistent with many reports in the literature (Jung et al, 2013;Tatsumi, Ohashi, Matsubara et al, 2013;Li et al, 2022). However, it is also necessary to exclude whether this is due to an allergic reaction.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…This is consistent with the alleviation of pulmonary embolism achieved by vascular expansion in the above reference. The symptoms of coma, decreased respiration, dilated pupils, decreased activity, and mental exhaustion in monkeys after repeated doses of hUC-MSCs (on the 3rd/4th dose prior to dilution of the concentration) may be typical of those associated with pulmonary embolism, consistent with many reports in the literature (Jung et al, 2013;Tatsumi, Ohashi, Matsubara et al, 2013;Li et al, 2022). However, it is also necessary to exclude whether this is due to an allergic reaction.…”
Section: Discussionsupporting
confidence: 79%
“…Frontiers in Cell and Developmental Biology frontiersin.org experiments and clinical trials (Lee, Seo, Pulin et al, 2009;Jung, Kwon, Choi et al, 2013;Liu, Chiang, Hung et al, 2017;Li, Huang, Zhang et al, 2022). When MSCs were infused into the systemic circulation rapidly, most of the MSCs were immediately entrapped in the lung.…”
Section: Discussionmentioning
confidence: 99%
“…The evaluation of the safety of UCMSCs, including assessment of toxicity, abnormal immunological reactions, biodistribution, and tumorigenicity, is a major focus in the development of “cell-based therapies” [ 23 ]. UCMSCs cultured in FBS or platelet lysates have been increasingly shown to be safe without deterioration [ 24 26 ]. However, the usage of FBS or platelet lysates makes standardization of cell manufacturing process difficult because of the poorly defined nature.…”
Section: Discussionmentioning
confidence: 99%
“…In the last 2 decades, the development of stem cells and regenerative medicine, as well as in-depth research on the pathophysiology of SCI, has provided new hope for its treatment ( Fan et al, 2022 ; Zhang et al, 2022 ). Stem cells can proliferate and self-renew under certain conditions and can further differentiate into multiple functional cells ( Ramotowski et al, 2019 ; Veneruso et al, 2019 ; Li et al, 2022 ). This new research direction has attracted the interest of many researchers, and a large amount of related literature has emerged.…”
Section: Introductionmentioning
confidence: 99%